The pharmaceutical industry imports in Chile have shown a notable increase over the past decade, standing at $3.15 billion in 2023. The year-on-year growth in 2023 was 14.09%, with a preceding two-year average annual growth rate of approximately 11.23%. Additionally, the compound annual growth rate (CAGR) over the past five years has been 13.92%, illustrating a strong upward trend.
Key Trends and Insights:
- The period between 2017 and 2023 witnessed significant oscillations with yearly growth rates spiking in 2018 (17.34%) and 2021 (38.59%), reflecting both market opportunities and external conditions potentially impacting demand and supply dynamics.
- From 2024 to 2028, the forecasted data projects a steady growth trajectory, with a forecasted five-year CAGR of 7.34%, suggesting sustained momentum but at a marginally slower pace compared to the recent past.
- The overall growth from 2013 to 2023 averaged around 9.51% annually, showcasing the expansion and increasing dependency of Chile on pharmaceutical imports.
Future Trends to Watch:
Factors to closely monitor include the impact of regulatory changes, innovation in pharmaceutical products, Chile's economic health, and global supply chain dynamics. Increasing public and private healthcare expenditure, the aging population, and potential shifts towards local production could also influence future import trends.
